Salison, Allan, JR.. B.
HRN: 17-00-30 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/08/2025
CEFUROXIME 1.5GM (VIAL)
11/08/2025
11/15/2025
IV DRIP
635mg
Q8
BFS; UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes